4D制药ADR吧
排序:
评论时间
  • 评论时间
  • 发帖时间
阅读评论标题 作者 最后更新
228 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 07-06 02:46
245 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 06-30 02:46
201 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 06-25 05:35
207 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 06-24 21:38
205 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 06-02 06:44
276 0 公告 Notice of Effectiveness 4D制药ADR资讯 04-29 18:47
218 0 公告 [Cover]Correspondence 4D制药ADR资讯 04-26 00:00
218 0 公告 [Cover]SEC-generated letter 4D制药ADR资讯 04-26 00:00
344 0 公告 Registration statement by foreign private issuers 4D制药ADR资讯 04-22 04:39
425 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 04-05 00:44
376 0 公告 Securities to be offered to employees in employee 4D制药ADR资讯 04-02 05:26
380 0 公告 Annual and transition report of foreign private is 4D制药ADR资讯 04-01 05:55
335 0 公告 Notice of Effectiveness 4D制药ADR资讯 03-31 19:09
363 0 公告 [Amend] Registration statement by foreign private 4D制药ADR资讯 03-29 05:50
303 0 公告 [Cover]Correspondence 4D制药ADR资讯 03-28 00:00
585 1 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 03-23 23:13
421 0 公告 Registration statement by foreign private issuers 4D制药ADR资讯 03-09 06:32
383 0 公告 [Amend] Statement of acquisition of beneficial own 4D制药ADR资讯 03-03 07:58
421 0 公告 Statement of acquisition of beneficial ownership b 4D制药ADR资讯 03-01 06:44
408 0 公告 Statement of acquisition of beneficial ownership b 4D制药ADR资讯 02-26 07:33
428 0 公告 [Amend] Report of foreign issuer [Rules 13a-16 and 4D制药ADR资讯 02-19 06:34
459 0 公告 Prospectus [Rule 424(b)(3)] 4D制药ADR资讯 02-19 06:26
404 0 公告 Prospectus [Rule 424(b)(3)] 4D制药ADR资讯 02-19 06:26
390 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 02-18 21:29
441 0 公告 [Amend] Statement of acquisition of beneficial own 4D制药ADR资讯 02-03 23:51
497 0 公告 Statement of acquisition of beneficial ownership b 4D制药ADR资讯 02-03 07:02
503 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 02-03 05:05
429 0 公告 Prospectus [Rule 424(b)(3)] 4D制药ADR资讯 01-11 05:00
429 0 公告 Prospectus [Rule 424(b)(3)] 4D制药ADR资讯 01-11 05:00
388 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 01-06 05:15
470 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 12-15 00:46
455 0 公告 Notice of Effectiveness 4D制药ADR资讯 10-15 18:50
407 0 公告 Prospectus [Rule 424(b)(3)] 4D制药ADR资讯 10-15 05:15
531 0 公告 [Amend] Registration statement for certain foreign 4D制药ADR资讯 10-07 18:26
504 0 公告 Post-Effective amendments for registration stateme 4D制药ADR资讯 10-01 18:51
486 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 10-01 18:42
477 0 公告 Prospectus [Rule 424(b)(3)] 4D制药ADR资讯 10-01 18:31
498 0 公告 Notice of Effectiveness 4D制药ADR资讯 10-01 00:00
528 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 09-30 18:44
489 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 09-24 05:07
624 0 公告 Registration statement for certain foreign private 4D制药ADR资讯 09-14 19:32
464 0 公告 Prospectus [Rule 424(b)(3)] 4D制药ADR资讯 08-12 03:47
558 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 08-02 23:41
583 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 07-28 05:48
463 0 公告 Prospectus [Rule 424(b)(3)] 4D制药ADR资讯 07-28 04:50
785 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 07-08 00:29
511 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 06-05 04:17
484 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 05-26 02:36
471 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 05-26 02:17
542 0 公告 Prospectus [Rule 424(b)(3)] 4D制药ADR资讯 05-25 21:10
506 0 公告 Notice of Effectiveness 4D制药ADR资讯 05-25 18:38
529 0 公告 Securities to be offered to employees in employee 4D制药ADR资讯 05-01 06:14
528 0 公告 [Amend] Annual and transition report of foreign pr 4D制药ADR资讯 05-01 05:39
557 0 公告 Registration statement for certain foreign private 4D制药ADR资讯 04-24 04:27
514 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 04-19 18:17
547 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 04-19 18:17
527 0 公告 Statement of acquisition of beneficial ownership b 4D制药ADR资讯 04-12 18:19
562 0 公告 Annual and transition report of foreign private is 4D制药ADR资讯 04-02 18:20
560 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 04-01 19:25
549 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 03-23 03:21
507 0 公告 Prospectuses and communications, business combinat 4D制药ADR资讯 03-19 02:13
584 0 公告 Certification by an exchange approving securities 4D制药ADR资讯 03-18 22:13
467 0 公告 Prospectuses and communications, business combinat 4D制药ADR资讯 03-18 05:03
486 0 公告 Prospectuses and communications, business combinat 4D制药ADR资讯 03-17 21:54
487 0 公告 Prospectus [Rule 424(b)(3)] 4D制药ADR资讯 03-09 05:35
613 0 公告 Prospectuses and communications, business combinat 4D制药ADR资讯 03-01 21:00
535 0 公告 Prospectuses and communications, business combinat 4D制药ADR资讯 03-01 21:00
538 0 公告 Prospectus [Rule 424(b)(3)] 4D制药ADR资讯 02-26 21:41
525 0 公告 Prospectuses and communications, business combinat 4D制药ADR资讯 02-26 21:34
507 0 公告 Prospectuses and communications, business combinat 4D制药ADR资讯 02-26 21:28
523 0 公告 Notice of Effectiveness 4D制药ADR资讯 02-26 20:26
552 0 公告 Notice of Effectiveness 4D制药ADR资讯 02-26 20:15
644 0 公告 [Amend] Registration of securities, foreign privat 4D制药ADR资讯 02-25 06:59
370 0 公告 SEC Staff Letter: REDACTED EXHIBIT 4D制药ADR资讯 02-25 00:00
475 0 公告 Registration of securities [Section 12(b)] 4D制药ADR资讯 02-24 07:45
481 0 公告 [Cover]Correspondence 4D制药ADR资讯 02-24 00:00
426 0 公告 [Amend] Registration of securities, foreign privat 4D制药ADR资讯 02-19 00:00
406 0 公告 Registration of American Depository Receipt shares 4D制药ADR资讯 02-18 00:00
399 0 公告 [Amend] Registration of securities, foreign privat 4D制药ADR资讯 02-16 00:00
394 0 公告 Prospectuses and communications, business combinat 4D制药ADR资讯 02-08 00:00
发表新主题
悬赏提问
帖子不见了!怎么办?   
   请登录 登录 | 5秒注册 作者: 退出 
郑重声明:用户在社区发表的所有资料、言论等仅代表个人观点,与本网站立场无关,不对您构成任何投资建议。用户应基于自己的独立判断,自行决定证券投资并承担相应风险。《东方财富社区管理规定》

扫一扫下载APP

扫一扫下载APP
信息网络传播视听节目许可证:0908328号 经营证券期货业务许可证编号:913101046312860336 违法和不良信息举报:021-34289898 举报邮箱:jubao@eastmoney.com
沪ICP证:沪B2-20070217 网站备案号:沪ICP备05006054号-11 沪公网安备 31010402000120号 版权所有:东方财富网 意见与建议:021-54509966/952500